Business Description
Ningxia Zhongke Biotechnology Co Ltd
NAICS : 331222
SIC : 3315
Hebin Street, Ningxia Hui Autonomous Region, Huinong District, Shizuishan, CHN, 750002
Compare
Compare
Traded in other countries / regions
600165.China
Description
Ningxia Zhongke Biotechnology Co Ltd formerly Ningxia Xinri Hengli Steel Wire Co Ltd is primarily involved in the production of wire products and machinery in China. The main products include round-strand wire rope, multi-layer strand wire rope, and other types of wire rope.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.16 | |||||
| Equity-to-Asset | 0.23 | |||||
| Debt-to-Equity | 1.33 | |||||
| Debt-to-EBITDA | 17.53 | |||||
| Interest Coverage | 0.13 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.65 | |||||
| Beneish M-Score | -1.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -29.7 | |||||
| 3-Year EBITDA Growth Rate | -18.4 | |||||
| 3-Year FCF Growth Rate | -0.4 | |||||
| 3-Year Book Growth Rate | 1.9 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.89 | |||||
| 9-Day RSI | 50.4 | |||||
| 14-Day RSI | 52.99 | |||||
| 6-1 Month Momentum % | -7.43 | |||||
| 12-1 Month Momentum % | 30.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.35 | |||||
| Quick Ratio | 0.25 | |||||
| Cash Ratio | 0.14 | |||||
| Days Inventory | 79.38 | |||||
| Days Sales Outstanding | 18.96 | |||||
| Days Payable | 338.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 15.83 | |||||
| Operating Margin % | 1.12 | |||||
| Net Margin % | 2.16 | |||||
| ROE % | 1.47 | |||||
| ROA % | 0.38 | |||||
| ROIC % | 0.18 | |||||
| ROC (Joel Greenblatt) % | 2.69 | |||||
| ROCE % | 2.53 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 588.33 | |||||
| PE Ratio without NRI | 580.49 | |||||
| PS Ratio | 12.4 | |||||
| PB Ratio | 9.34 | |||||
| Price-to-Tangible-Book | 10.27 | |||||
| Price-to-Operating-Cash-Flow | 143.14 | |||||
| EV-to-EBIT | 135.56 | |||||
| EV-to-EBITDA | 135.56 | |||||
| EV-to-Revenue | 13.66 | |||||
| EV-to-FCF | -106.24 | |||||
| Price-to-Median-PS-Value | 2.52 | |||||
| Price-to-Graham-Number | 16.2 | |||||
| Earnings Yield (Greenblatt) % | 0.74 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 583.228 | ||
| EPS (TTM) (¥) | 0.018 | ||
| Beta | 2.17 | ||
| Volatility % | 72.83 | ||
| 14-Day RSI | 52.99 | ||
| 14-Day ATR (¥) | 0.426556 | ||
| 20-Day SMA (¥) | 10.2675 | ||
| 12-1 Month Momentum % | 30.16 | ||
| 52-Week Range (¥) | 6.25 - 13.88 | ||
| Shares Outstanding (Mil) | 684.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ningxia Zhongke Biotechnology Co Ltd Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||